about
Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.Identification of a novel negative regulator of activin/nodal signaling in mesendodermal formation of Xenopus embryos.Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Xenopus Dab2 is required for embryonic angiogenesis
@ast
Xenopus Dab2 is required for embryonic angiogenesis
@en
Xenopus Dab2 is required for embryonic angiogenesis.
@nl
type
label
Xenopus Dab2 is required for embryonic angiogenesis
@ast
Xenopus Dab2 is required for embryonic angiogenesis
@en
Xenopus Dab2 is required for embryonic angiogenesis.
@nl
prefLabel
Xenopus Dab2 is required for embryonic angiogenesis
@ast
Xenopus Dab2 is required for embryonic angiogenesis
@en
Xenopus Dab2 is required for embryonic angiogenesis.
@nl
P2093
P2860
P356
P1476
Xenopus Dab2 is required for embryonic angiogenesis
@en
P2093
Jin-Kwan Han
Seong-Moon Cheong
Sun-Cheol Choi
P2860
P2888
P356
10.1186/1471-213X-6-63
P577
2006-12-19T00:00:00Z
P6179
1045852477